Galenica Sante AG Total Assets
Galenica Sante AG total assets. Based on the latest financial reports, Galenica Sante AG (GALE) holds total assets worth CHF3.34 Billion CHF (≈ $4.23 Billion USD) as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see GALE market cap overview for the company's overall valuation and market capitalisation.
Total Assets of Galenica Sante AG (2013–2025)
Total assets of Galenica Sante AG from 2013 to 2025. This chart illustrates how Galenica Sante AG's total assets have evolved over time, based on quarterly financial data. See GALE live share price for real-time trading data and today's change.
Galenica Sante AG - Asset Composition Analysis
Galenica Sante AG Total Assets Breakdown (December 2025)
Galenica Sante AG total assets breakdown as of December 2025. Galenica Sante AG's total assets of CHF3.34 Billion consist of 32.0% current assets and 68.0% non-current assets.
| Asset Category | Amount (CHF) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CHF115.51 Million | 3.5% |
| Accounts Receivable | CHF526.78 Million | 15.8% |
| Inventory | CHF385.40 Million | 11.5% |
| Property, Plant & Equipment | CHF511.49 Million | 15.3% |
| Intangible Assets | CHF372.65 Million | 11.1% |
| Goodwill | CHF1.04 Billion | 31.1% |
Asset Composition Trend (2013–2025)
This chart illustrates how Galenica Sante AG's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore GALE working capital ratio to assess how much short-term liquidity the company maintains relative to its equity base.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Galenica Sante AG's current assets represent 32.0% of total assets in 2025, a decrease from 45.1% in 2013.
- Cash Position: Cash and equivalents constituted 3.5% of total assets in 2025, up from 1.1% in 2013.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 42.0% of total assets, an increase from 28.0% in 2013.
- Asset Diversification: The largest asset category is goodwill at 31.1% of total assets.
Galenica Sante AG Competitors by Total Assets
Key competitors of Galenica Sante AG based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
China National Medicines Corp Ltd
SHG:600511
|
China | CN¥35.13 Billion |
|
Guangxi Liuzhou Pharm Co Ltd
SHG:603368
|
China | CN¥21.18 Billion |
|
TELES Informationstechnologien AG
XETRA:TLIK
|
Germany | €4.29 Million |
|
Sigma Healthcare Ltd
AU:SIG
|
Australia | AU$8.74 Billion |
|
Ebos Group Ltd
AU:EBO
|
Australia | AU$8.80 Billion |
|
Paragon Care Ltd
AU:PGC
|
Australia | AU$1.31 Billion |
|
Mayne Pharma Group Ltd
AU:MYX
|
Australia | AU$1.01 Billion |
|
Farmaceutica R
RO:RMAH
|
Romania | RON345.32 Million |
Galenica Sante AG - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.15 | 1.41 | 1.49 |
| Quick Ratio | 0.73 | 0.91 | 0.92 |
| Cash Ratio | 0.12 | 0.18 | 0.11 |
| Working Capital | CHF136.96 Million | CHF300.07 Million | CHF265.28 Million |
Galenica Sante AG - Advanced Valuation Insights
This section examines the relationship between Galenica Sante AG's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 2.78 |
| Latest Market Cap to Assets Ratio | 1.22 |
| Asset Growth Rate (YoY) | 8.9% |
| Total Assets | CHF3.34 Billion |
| Market Capitalization | $4.09 Billion USD |
Valuation Analysis
Above Book Valuation: The market values Galenica Sante AG's assets above their book value (1.22x), reflecting positive investor sentiment about the company's future prospects.
Positive Asset Growth: Galenica Sante AG's assets grew by 8.9% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Galenica Sante AG (2013–2025)
The table below shows the annual total assets of Galenica Sante AG from 2013 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | CHF3.34 Billion ≈ $4.23 Billion |
+8.91% |
| 2024-12-31 | CHF3.07 Billion ≈ $3.88 Billion |
+2.67% |
| 2023-12-31 | CHF2.99 Billion ≈ $3.78 Billion |
+12.29% |
| 2022-12-31 | CHF2.66 Billion ≈ $3.37 Billion |
+1.83% |
| 2021-12-31 | CHF2.62 Billion ≈ $3.31 Billion |
+15.79% |
| 2020-12-31 | CHF2.26 Billion ≈ $2.86 Billion |
+2.23% |
| 2019-12-31 | CHF2.21 Billion ≈ $2.79 Billion |
+18.79% |
| 2018-12-31 | CHF1.86 Billion ≈ $2.35 Billion |
+3.44% |
| 2017-12-31 | CHF1.80 Billion ≈ $2.27 Billion |
-9.44% |
| 2016-12-31 | CHF1.99 Billion ≈ $2.51 Billion |
+14.59% |
| 2015-12-31 | CHF1.73 Billion ≈ $2.19 Billion |
+1.39% |
| 2014-12-31 | CHF1.71 Billion ≈ $2.16 Billion |
-0.98% |
| 2013-12-31 | CHF1.73 Billion ≈ $2.18 Billion |
-- |
About Galenica Sante AG
Galenica AG provides healthcare services in Switzerland and internationally. It operates through two segments, Products & Care, and Logistics & IT. The Products & Care segment operates and manages pharmacies and partner pharmacies under the Amavita, Sun Store, and Coop Vitality brands, as well as covers specialty pharmacy mediservice. This segment also offers medication for treatment of patients … Read more